›› 2010, Vol. 30 ›› Issue (2): 87-94.

• 论文 • 上一篇    下一篇

体外替代安全评价方法的验证-代谢性相互作用对细胞毒性的影响

  

  1. 1.复旦大学药学院,上海 201023;2.上海浦东出入境检验检疫局,上海 200135;3.瑞德肝脏疾病研究(上海)有限公司,上海 201023
  • 收稿日期:2009-09-08 出版日期:2010-02-28 发布日期:2010-02-28

Validation of Alternative Method for Evaluating Effects of Drug Metabolism on Cytotoxicity

  1. 1.Department of Pharmacological School of Pharmacy, Fudan University,Shanghai 201203, China;2.Pudong Entry-Exit Inspection & Quarantine Bureau of China, Shanghai 200135, China.3.Research Institute for Liver Diseases (Shanghai) Co.,Ltd., Shanghai 201203, China
  • Received:2009-09-08 Online:2010-02-28 Published:2010-02-28
  • Supported by:
    Science and Technology Plan Project from Shanghai Inspection and Quarantine Bureau(No.HK047-2007).

摘要: 目的 随着近20年实验动物伦理原则的逐步普及,学术界、工业界和政府管理部门开始研究和推广动物试验的替代方法,用于药品、食品和化妆品的安全评价.美国15个政府管理机构和研究机构成立了"替代评价方法协调委员会(ICCVAM)"并指定和验证了评价方法.作者按照ICCVAM推荐的方法,应用体外细胞毒性评价方法和代谢性相互作用评价方法,研究出入境天然产物制品的毒性作用及其代谢性活化或代谢性解毒机制.方法 用人肝微粒体,研究了天然产物制品对肝细胞色素P450亚酶的作用.用超低温冻存的人肝原代细胞,评价了5个进口天然产物制品的细胞毒性(MTT方法).应用化学抑制法,研究了细胞色素P4502A6,2C9,2C19和3A4对天然产物制品细胞毒性的影响.结果 天然产物制品TA-07-004和TA-07-005对CYP1A2有明显的抑制作用,它们的IC50分别为初始浓度的0.22%和0.03%,且它们对CYP3A4也有明显的抑制作用,它们的IC50分别为初始浓度的0.49%和0.20%.天然产物制品TA-07-003没有肝细胞毒性,其余4个天然产物制品观察到有肝细胞毒性,它们的IC50分别为初始浓度的0.37%,0.26%,0.62%和0.19%.在研究与天然产物制品TA-07-005细胞毒性有关的细胞色素P450亚型酶中,发现CYP2C9、CYP2A6、CYP2C19和CYP3A4活性被抑制后能减轻TA-07-005对肝细胞的毒性,说明TA-07-005被CYP450生物活化后毒性增加.结论 用人原代肝细胞模型为基础的替代方法研究细胞毒性及代谢性相互作用对细胞毒性的影响是可行的.

关键词: 替代方法, 天然产物制品, 细胞色素P450, 细胞毒性, 生物活化, 人原代肝细胞

Abstract: Objective With increased concerns and gradual progress on the ethical use of experi-mental animals in the past decades, the development, and validation of new and revised non-animal and reliable alternative methods have been approached by academia, industry and government regulators in order to reduce the number of animals, and refine the procedures to lessen or eliminate pain and distress to animals, and replace animals with non-animal systems. According to the methods recommended by "The Interagency Coordinating Committee on the Validation of Alternative Methods(ICCVAM)" in USA,priority for alternative methods has been placed on basal cytotoxicity methods and additional efforts are on incorporating in vitro cytotoxic data with in vitro parameters of absorption, distribution, metabolism,excretion, and toxicity(ADMET). This study was to validate an alternative ADMET method by using human primary hepatocytes. Method Human liver microsomes were used to evaluate the effects of natural products on CYP450 isoforms. Basal cytotoxicity of 5 imported natural products was estimated by using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT), and effects of metabolism by CYP450 isoforms on cytotoxicity of natural products was evaluated by using chemical inhibitors of CYP2A6, 2C9, 2C19, and 3A4 preincubation with human primary hepatocytes. Results The inhibitory potential(IC50) of natural products (TA-07-004, TA-07-005) on CYP1A2 were 0.22%and 0.03%, CYP 3A4 were 0.49% and 0.20% of the initial concentration, respectively.The hepatotoxicity,IC50 values were 0.37%, 0.26%, 0.62%, 0.19% of original concentrations for TA-07-001, TA-07-002,TA-07-004, and TA-07-005, respectively. No cytotoxicity was observed for TA-07-003. Preincubation of selective inhibitors for CYP450 isoforms with primary hepatocytes showed that cytotoxicity of TA-07-005 was reduced by inhibition of CYP2A6, 2C9, 2C19, 3A4, suggesting that TA-07-005 might be bioactivated by CYP450. Conclusions The In vitro hepatotoxic model with in vitro metabolism assay provided a valuable and feasible alternative procedure for estimating metabolism dependent toxic potentials of test materials as natural products.

Key words: Alternative methods, Natural product, Cytochrome P450 (CYP450s), Cytotoxicity, Bioactivation, Human primary hepatocytes